Olumiant
- Product NDC
- 0002-4732
- 11-digit product format
- 000024732
- Labeler code
- 0002
- Product ID
- 0002-4732_609e7391-6d27-4d0d-bd00-f9cdb75a3070
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- baricitinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Eli Lilly and Company
- Application
- NDA207924
- Marketing category
- NDA
- Marketing start
- 2019-10-08
- Substance
- BARICITINIB
- Active strength
- 1 mg/1
- Pharmacologic classes
- Janus Kinase Inhibitor [EPC], Janus Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Olumiant
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BARICITINIB | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | ISP4442I3Y |
| Rxcui | 2047241, 2047247, 2205472, 2205474, 2588561, 2601725 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0002-4732-30 | Olumiant | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 28 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0002-4732 | OLUMIANT (BARICITINIB) TABLET, FILM COATED [ELI LILLY AND COMPANY] | 23 | Current NDC, Legacy NDC, 1 package rows | 20241206_866e9f35-9035-4581-a4b1-75a621ab55cf.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0002-4732-30 | 00002473230 | 30 TABLET, FILM COATED in 1 BOTTLE (0002-4732-30) | 2019-10-08 | 0000-00-00 | No | No | Current |